Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Greenberg

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Muscle & Nerve|October 10, 2014
Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiencyNicholas Morris, Karen Lynch, Steven A Greenberg
Neurology|August 29, 2022
Quantitative MRI Biomarkers as Potential Inclusion Body Myositis Clinical Trial EndpointsSteven A Greenberg, Alex Dmitrienko, Mark Hayes
Muscle & Nerve|July 11, 2006
Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositisSteven A Greenberg, Jack L Pinkus, Anthony A Amato
Current Sports Medicine Reports|July 8, 2025
Web AlertWilliam W Dexter, Steven A Greenberg, Justin S Ham
Plos One|June 11, 2013
Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15Sara Franzi, Mohammad Salajegheh, Remedios Nazareno, et al.
Neurology|May 27, 2014
Inclusion body myositis and chronic lymphocytic leukemia: a case seriesElizabeth H Beck, Anthony A Amato, Steven A Greenberg
Muscle & Nerve|August 12, 2009
Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host diseaseJeffrey A Allen, Steven A Greenberg, Anthony A Amato
Muscle & Nerve|November 25, 2015
Anti- C N1A antibodies in South Australian patients with inclusion body myositisVidya S Limaye, Sue Lester, Peter Blumbergs, et al.
Oncotarget|March 13, 2019
Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer modelsSteven A Greenberg, Sek Won Kong, Evan Thompson, et al.
Current Medical Research and Opinion|June 8, 2018
Health care costs and comorbidities for patients with inclusion body myositisAllison Keshishian, Steven A Greenberg, Neetu Agashivala, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Muscle & Nerve|October 10, 2014
Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiencyNicholas Morris, Karen Lynch, Steven A Greenberg
Neurology|August 29, 2022
Quantitative MRI Biomarkers as Potential Inclusion Body Myositis Clinical Trial EndpointsSteven A Greenberg, Alex Dmitrienko, Mark Hayes
Muscle & Nerve|July 11, 2006
Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositisSteven A Greenberg, Jack L Pinkus, Anthony A Amato
Current Sports Medicine Reports|July 8, 2025
Web AlertWilliam W Dexter, Steven A Greenberg, Justin S Ham
Plos One|June 11, 2013
Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15Sara Franzi, Mohammad Salajegheh, Remedios Nazareno, et al.
Neurology|May 27, 2014
Inclusion body myositis and chronic lymphocytic leukemia: a case seriesElizabeth H Beck, Anthony A Amato, Steven A Greenberg
Muscle & Nerve|August 12, 2009
Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host diseaseJeffrey A Allen, Steven A Greenberg, Anthony A Amato
Muscle & Nerve|November 25, 2015
Anti- C N1A antibodies in South Australian patients with inclusion body myositisVidya S Limaye, Sue Lester, Peter Blumbergs, et al.
Oncotarget|March 13, 2019
Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer modelsSteven A Greenberg, Sek Won Kong, Evan Thompson, et al.
Current Medical Research and Opinion|June 8, 2018
Health care costs and comorbidities for patients with inclusion body myositisAllison Keshishian, Steven A Greenberg, Neetu Agashivala, et al.
Pageof 11